公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2009 | Effect of Macroscopic Vascular Invasion (Mvi), Extrahepatic Spread (Ehs), and Ecog Performance Status (Ecog Ps) on Outcome in Patients with Advanced Hepatocellular Carcinoma (Hcc) Treated with Sorafenib: Analysis of Two Phase Iii, Randomized, Double-Blind | CHENG, ANN-LII; TSAO, CHAO-JUNG; 鄭安理 | JOURNAL OF CLINICAL ONCOLOGY | | | |
2015 | Efficacy and safety of nintedanib (N) versus sorafenib (S) in Caucasian and Asian patients with advanced hepatocellular carcinoma (HCC): Pooled analysis of two randomized phase II trials. | Meyer, Tim; Palmer, Daniel H.; Chao, Yee; Choi, Caren; Deptala, Andrzej; Fartoux, Laetitia; Feng, Yin-Hsun; Graham, Janet Shirley; Hocke, Julia; Kim, Tae-You; Lin, Deng-Yn; Ma, Yuk Ting; Peck-Radosavljevic, Markus; Ross, Paul J.; Ryoo, Baek-Yeol; Wenz, Arne; Yen, Chia-Jui; Loembe, Arsene-Bienvenu; Cheng, Ann-Lii | J. Clin. Oncol. | | | |
2015 | Efficacy and safety of nintedanib (N) versus sorafenib (S) in Caucasian and Asian patients with advanced hepatocellular carcinoma (HCC): Pooled analysis of two randomized phase II trials. | Meyer, Tim; Palmer, Daniel H.; Chao, Yee; Choi, Caren; Deptala, Andrzej; Fartoux, Laetitia; Feng, Yin-Hsun; Graham, Janet Shirley; Hocke, Julia; Kim, Tae-You; Lin, Deng-Yn; Ma, Yuk Ting; Peck-Radosavljevic, Markus; Ross, Paul J.; Ryoo, Baek-Yeol; Wenz, Arne; Yen, Chia-Jui; Loembe, Arsene-Bienvenu; Cheng, Ann-Lii; 鄭安理 | J. Clin. Oncol. | | | |
2009 | Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma (Hcc): Asia-Pacific (Ap) Trial Subgroup Analyses by Baseline Transaminase (Alt/Ast)/(Alpha)-Fetoprotein (Afp) Levels | TSAO, CHAO-JUNG; CHENG, ANN-LII; 鄭安理 | JOURNAL OF CLINICAL ONCOLOGY | | | |
2009 | Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma (Hcc): Collective Results from the Phase Iii Sorafenib Hcc Assessment Randomized Protocol (Sharp) and Asia-Pacific (Ap) Trials | CHENG, ANN-LII; 鄭安理 | EJC SUPPLEMENTS | | | |
2021 | An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma | Shen, Ying-Chun; Lee, Pei-Chang; Kuo, Yu-Lun; WEI-KAI WU ; Chen, Chieh-Chang; Lei, Chengh-Hau; Yeh, Ching-Ping; CHIUN HSU; CHIH-HUNG HSU; Lin, Zhong-Zhe; Shao, Yu-Yun; Lu, Li-Chun; Liu, Tsung-Hao; Chen, Chien-Hung; Wu, Ming-Shiang; Huang, Yi-Hsiang; Cheng, Ann-Lii | Journal of hepatocellular carcinoma | | 14 | |
1991 | Expression of Growth-Related Genes and Drug-Resistance Genes in HTLV-I-Positive and HTLV-I-Negative Post-Thymic T-Cell Malignancies | Su, I. J.; Chang, I. C.; Cheng, Ann-Lii; 鄭安理 | Annals Oncology | | | |
1993 | Expression of P-Glycoprotein and Glutathione-S-Transferase in Recurrent Lymphoma:The Possible Role of Epstein-Barr Virus, Immunophenotypes, and Other Predisposing Factors | Cheng, Ann-Lii; Chen, Yee-Chun; 鄭安理 | Journal of Clinical Oncology | | | |
1997 | Factors Associated with the Therapeutic Efficacy of Retinoic Acids on Malignant Lymphomas | CHENG, ANN-LII; CHUANG, SHUANG-EN; LIN, CHIEN-HSING; LUO, YOU-JEN; PU, YEONG-SHIAU; SU, IH-JEN; 鄭安理 | JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | | | |
2007 | Gemcitabine Is Preferentially Chemosensitive in Cyclin D1 or Cyclin E over-Expressing Human Gastric Cancer Cells | SHEN, YING-CHUN; CHENG, ANN-LII; 鄭安理 | ANNALS OF ONCOLOGY | | | |
2013 | Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: a meta-analysis and meta-regression (vol 15, pg 265, 2012) | Hsu, Chiun; Shen, Ying-Chun; Cheng, Chia-Chi; Cheng, Ann-Lii; Hu, Fu-Chang; Yeh, Kun-Huei | Gastric Cancer | | | |
2013 | Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: a meta-analysis and meta-regression (vol 15, pg 265, 2012) | Hsu, Chiun; Shen, Ying-Chun; Cheng, Chia-Chi; Cheng, Ann-Lii; Hu, Fu-Chang; Yeh, Kun-Huei; 鄭安理 | Gastric Cancer | | | |
2015 | Heterogeneous cell origin of Helicobater pylori-dependent high-grade gastric lymphomas. | Kuo, Sung Hsin; Chen, Li-Tzong; Lin, Chung-Wu; Yeh, Kun-Huei; Tsai, Hui-Jen; Lee, Hsiao-Wei; Wu, Ming-Shiang; Hsu, Ping-Ning; Cheng, Ann-Lii | J. Clin. Oncol. | | | |
2014 | High serum transforming growth factor beta 1 levels associated with poor survivals in patients with advanced hepatocellular carcinoma | Lin, Tzu-Hsuan; Shao, Yu-Yun; Chan, Soa-Yu; Huang, Chung-Yi; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Cancer Res. | 0 | 0 | |
2013 | Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma | Lu, Li-Chun; Shao, Yu-Yun; Kuo, Raymond N. C.; Lin, Zhong-Zhe; Yeh, Yi-Chun; Shau, Wen-Yi; Hsu, Chih-Hung; Cheng, Ann-Lii; Lai, Mei-Shu | Cancer | | | |
1999 | Hypermethylation of the P16 Gene in Sporadic T3n0m0 Stage Colorectal Cancers: Association with DNA Replication Error and Shorter Survival | Liang, Jin-Tung; Chang, King-Jen; Chen, Jeng-Chang; Lee, Chun-Chung; Cheng, Yung-Ming; Hsu, Hey-Chi; Wu, Ming-Shiang; Wang, Shih-Ming; Lin, Jaw-Town; Cheng, Ann-Lii | ONCOLOGY | | | |
2009 | Impact of Lung and Lymph Node Metastasis on Efficacy and Safety Following Treatment with Sorafenib in Patients with Hepatocellular Carcinoma from the Asia-Pacific Region | CHENG, ANN-LII; 鄭安理 | JOURNAL OF HEPATOLOGY | | | |
2009 | Impact of Prior Surgical Resection with Curative Intent on the Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma (Hcc): Subset Analysis of the Asia-Pacific (Ap) Study | TSAO, CHAO-JUNG; CHENG, ANN-LII; 鄭安理 | JOURNAL OF CLINICAL ONCOLOGY | | | |
2009 | Impact of Prior Tace/Tae on the Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma (Hcc) from the Asia- Pacific Region | CHENG, ANN-LII; 鄭安理 | JOURNAL OF HEPATOLOGY | | | |
2002 | Increase of the Resistance of Human Cervical Carcinoma Cells to Cisplatin by Inhibition of the Mek to Erk Signaling Pathway Partly Via Enhancement of Anticancer Drug-Induced Nf Kappa B Activation | CHENG, ANN-LII; 鄭安理 | BIOCHEMICAL PHARMACOLOGY | | | |